Cancer immunotherapies: advances and bottlenecks

Immunotherapy has ushered in a new era in cancer treatment, and cancer immunotherapy continues to be rejuvenated. The clinical goal of cancer immunotherapy is to prime host immune system to provide passive or active immunity against malignant tumors. Tumor infiltrating leukocytes (TILs) play an immu...

Celý popis

Podrobná bibliografia

Vydané v:	Frontiers in immunology Ročník 14; s. 1212476
Hlavní autori:	Rui, Rui, Zhou, Liqun, He, Shiming
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Frontiers Media S.A 24.08.2023
Predmet:	cancer immunotherapy immune checkpoint blockade Immunology neoadjuvant immunotherapy tumor microenvironment
ISSN:	1664-3224, 1664-3224
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!